Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
M Andrea, T Weinschenk, S Colette… - US Patent App. 17 …, 2022 - Google Patents
2021-12-17 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Circulating biomarkers for nonfunctional gastroenteropancreatic neuroendocrine neoplasm: Where do we stand?
P Zhang, L Shen - Oncology and Translational Medicine, 2017 - journals.lww.com
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) encompass a
heterogeneous group of tumors associated with variable presentations, growth rates, and …
heterogeneous group of tumors associated with variable presentations, growth rates, and …
Identification of membrane associated proteins as potential markers for the DLKP clonal subpopulations
A McCann - 2016 - doras.dcu.ie
Lung cancer is one of the major causes of cancer death worldwide, it represents a
heterogeneous group of tumours with distinct morphological, histological and molecular …
heterogeneous group of tumours with distinct morphological, histological and molecular …
[引用][C] Clinical characteristics, biomarkers and treatment outcome of GEP-NENs in China
L Chen, M Chen, J Chen